Literature DB >> 26835279

HIF-1α siRNA reduces retinal neovascularization in a mouse model of retinopathy of prematurity.

Hui-Zhuo Xu1, Shuang-Zhen Liu1, Si-Qi Xiong1, Xiao-Bo Xia1.   

Abstract

OBJECTIVE: To explore the effect of HIF-1α specific siRNA expression vector pSUPERH1-siHIF-1α on retinal neovascularization in a mouse model of retinopathy of prematurity (ROP).
METHODS: Forty-eight newborn C57BL/6J mice were randomly divided into the control and experimental groups (n=24 apiece) to create the model of ROP following the methods described by Smith et al. Twelve days after birth, the experimental group received intravitreal injection with pSUPERH1-siHIF-1α; meanwhile, mice in the control group were injected with empty vectors. The expressions of HIF-1α and vascular endothelia growth factor (VEGF) in the retina were examined by Western blotting in both groups. The differences in the neovascular endothelial cell count were compared based on the FITC-Dextran fluorescence stretched preparation/sections.
RESULTS: Compared with the control group, the expressions of HIF-1α and VEGF significantly decreased in the experimental group (P<0.01). Meanwhile, the number of retinal neovascular endothelial nuclei that had protruded the internal limiting membrane was significantly lower in the experimental group than in control group (P<0.01).
CONCLUSIONS: RNA interference targeting HIF-1α can effectively inhibit the retinal neovascularization of ROP.

Entities:  

Keywords:  Hypoxia inducible factor-1α; RNA interference; mice; retinal neovascularization; retinopathy of prematurity

Year:  2013        PMID: 26835279      PMCID: PMC4728947          DOI: 10.3978/j.issn.2224-4336.2012.03.01

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  22 in total

Review 1.  Hydroxylation of HIF-1: oxygen sensing at the molecular level.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2004-08

Review 2.  Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications.

Authors:  Johanna Westra; Grietje Molema; C G M Kallenberg
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1984-08

Review 4.  Retinopathy of prematurity.

Authors:  Jing Chen; Lois E H Smith
Journal:  Angiogenesis       Date:  2007-02-27       Impact factor: 9.596

5.  Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.

Authors:  H Ozaki; A Y Yu; N Della; K Ozaki; J D Luna; H Yamada; S F Hackett; N Okamoto; D J Zack; G L Semenza; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

6.  HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.

Authors:  Manuela Bartoli; Mohamed Al-Shabrawey; Mohamed Labazi; M Ali Behzadian; Mohamed Istanboli; Azza B El-Remessy; Robert W Caldwell; Dennis M Marcus; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-20       Impact factor: 4.799

7.  Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.

Authors:  S Kusaka; C Shima; K Wada; H Arahori; H Shimojyo; T Sato; T Fujikado
Journal:  Br J Ophthalmol       Date:  2008-07-11       Impact factor: 4.638

8.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

Review 9.  Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Authors:  Rafael Simó; Esther Carrasco; Marta García-Ramírez; Cristina Hernández
Journal:  Curr Diabetes Rev       Date:  2006-02

Review 10.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.